Contribuição da densidade do PSA para predizer o câncer da próstata em pacientes com valores de PSA entre 2,6 e 10,0 ng/ml

(3) assessed the effects of DRE in 71 patients with prostate pathologies and 72 controls and found that some individuals with ini- tial PSA values up to 4.0 ng/mL presented a

The authors concluded that staging bone scan could be omitted in patients with a PSA level of ≤ 20 ng/mL, and Gleason.. score

Baseline PSA level was 1.32 ng/mL in African American men and 1.27 ng/mL in Caucasian men, and there was no signiicant difference in PSA between racial groups at 6-month intervals,

Background: Prostate cancer (PCa) patients with pretreatment prostate-speciic antigen (PSA) >20 ng/ml have a high risk of biochemical and clinical failure and even

The analysis of patients with high-risk PCa, defined by a serum PSA concentration greater than 10 ng/ml, a Gleason score greater than 6 or a per- centage of positive biopsy cores

the effectiveness of the PSA-AV cut-off of 700 com- pared with a PSA cut-off of 4ng/mL are similar for predicting positive biopsy findings, considering all age groups and

Enquanto membro do Plano Internacional de Ação para o Envelhecimento adotado na Primeira Assembléia Mundial (ONU, 1982), o Brasil precisou implementar políticas em prol dos

Analisar o NDVI gerado pela reflectância da cobertura florestal, assim como a relação entre os valores de IAF obtidos através do processamento de imagens oriundas do